Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study

被引:2
|
作者
Zhu, Juan [1 ,2 ]
Sun, Kexin [1 ]
Wang, Jian [3 ]
He, Yutong [4 ]
Li, Daojuan [4 ]
Liu, Shuzheng [5 ]
Huang, Yunchao [6 ]
Zhang, Min [7 ]
Song, Bingbing [8 ]
Liao, Xianzhen [9 ,10 ]
Liang, He [11 ,12 ]
Zhang, Qian [13 ]
Shi, Mumu [14 ]
Guo, Lanwei [5 ]
Zhou, Yongchun [6 ]
Lin, Yanping [6 ]
Lu, Yanni [6 ]
Tuo, Jiyu [7 ]
Xia, Yafen [7 ]
Sun, Huixin [8 ]
Xiao, Haifan [9 ,10 ]
Ji, Yong [12 ,15 ]
Yan, Ci [13 ]
Qiao, Jinwan [14 ]
Zeng, Hongmei [1 ]
Zheng, Rongshou [1 ]
Zhang, Siwei [1 ]
Liu, Shaoyan [3 ]
Chang, Sheng [16 ]
Wei, Wenqiang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr,Off Natl Cent Canc Registry, Beijing, Peoples R China
[2] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Canc & Basic Med IBMC, Zhejiang Canc Hosp,Canc Hosp,Dept Canc Prevent, Hangzhou, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Head & Neck Surg,Natl Canc Ctr, Beijing, Peoples R China
[4] Hebei Med Univ, Hosp 4, Canc Inst, Shijiazhuang, Hebei, Peoples R China
[5] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Henan Canc Prevent & Control Off, Zhengzhou, Peoples R China
[6] Yunnan Canc Hosp, Off Yunnan Canc Ctr, Kunming, Yunnan, Peoples R China
[7] Hubei Canc Hosp, Off Canc Prevent & Treatment, Wuhan, Peoples R China
[8] Harbin Med Univ, Inst Canc Prevent & Treatment, Heilongjiang Canc Ctr, Harbin, Peoples R China
[9] Cent South Univ, Hunan Canc Hosp, Dept Canc Prevent & Control, Changsha, Peoples R China
[10] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China
[11] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Sci Res Educ Dept,Natl Canc Ctr, Shenzhen, Peoples R China
[12] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen, Peoples R China
[13] Xinjiang Med Univ, Tumor Hosp, Informat Management & Big Data Ctr, Urumqi, Peoples R China
[14] Fifth Peoples Hosp Qinghai, Sci & Educ Dept, Xining, Peoples R China
[15] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Med Dept,Natl Canc Ctr, Shenzhen, Peoples R China
[16] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Human Resources Off,Natl Canc Ctr, Beijing, Peoples R China
关键词
thyroid cancer; differentiated thyroid carcinoma; stage; surgery; lobectomy; total thyroidectomy; BMI; China; DIAGNOSIS; TRENDS; IMPACT; MORTALITY; EPIDEMIC; SURVIVAL; RISK; MICROCARCINOMA; DISPARITIES; GUIDELINES;
D O I
10.3389/fpubh.2022.974359
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. MethodsWe carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate associations between influencing factors and DTC stage. We extracted eligible primary DTC records newly diagnosed in 2017 from the USA's Surveillance, Epidemiology, and End Results (SEER) database. We compared clinicopathological features and surgical treatment between our DTC records and those from the SEER database. ResultsA total of 1970 eligible patients were included, with 1861 DTC patients with known stage. Among patients >= 45 years old, males (OR = 1.76, 95%CI 1.17-2.65) and those with new rural cooperative medical scheme insurance (NCMS) (OR = 1.99, 95%CI 1.38-2.88) had higher risks of late-stage DTC (stage III-IV). Compared with SEER database, over-diagnosis is more common in China [more DTC patients with onset age< 45 years old (50.3 vs. 40.7%, P < 0.001), with early-stage (81.2 vs. 76.0%, P < 0.001), and with tumors<2cm (74.9 vs. 63.7%, P < 0.001)]. Compared with the USA, TC treatment is more conservative in China. The proportion of lobectomy in our database was significantly higher than that in the SEER database (41.3 vs. 17.0%, P < 0.001). ConclusionsUnique risk factors are found to be associated with late-stage DTC in China. The differences in the aspect of clinicopathological features and surgical approaches between China and the USA indicate that potential over-diagnosis and over-surgery exist, and disparities on surgery extent may need further consideration. The findings provided references for other countries with similar patterns.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Clinicopathological and therapeutic comparisons of esophageal cancer between China and the USA: a multicenter hospital-based study
    Zhu, Juan
    Du, Lingbin
    Li, Huizhang
    Ran, Xianhui
    Zeng, Hongmei
    Wei, Wenqiang
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (04): : 318 - 325
  • [2] Menstrual, reproductive and hormonal factors and thyroid cancer: a hospital-based case-control study in China
    Wang, Meng
    Gong, Wei-Wei
    He, Qing-Fang
    Hu, Ru-Ying
    Yu, Min
    BMC WOMENS HEALTH, 2021, 21 (01)
  • [3] The association between diabetes and thyroid cancer risk: a hospital-based case-control study in China
    Wang, Meng
    Gong, Wei-Wei
    Lu, Feng
    Hu, Ru-Ying
    He, Qing-Fang
    Yu, Min
    BMC ENDOCRINE DISORDERS, 2021, 21 (01)
  • [4] The association between diabetes and thyroid cancer risk: a hospital-based case-control study in China
    Meng Wang
    Wei-Wei Gong
    Feng Lu
    Ru-Ying Hu
    Qing-Fang He
    Min Yu
    BMC Endocrine Disorders, 21
  • [5] A positive association between nutritional risk and the incidence of surgical site infections: A hospital-based register study
    Skeie, Eli
    Koch, Anne Mette
    Harthug, Stig
    Fosse, Unni
    Sygnestveit, Kari
    Nilsen, Roy Miodini
    Tangvik, Randi J.
    PLOS ONE, 2018, 13 (05):
  • [6] Clinicopathological study of lip cancer: a retrospective hospital-based study in Taiwan
    Tseng, Hui-Wen
    Liou, Huei-Han
    Tsai, Kuo-Wang
    Ger, Luo-Ping
    Shiue, Yow-Ling
    APMIS, 2017, 125 (11) : 1007 - 1016
  • [7] The challenges of returning to work for differentiated thyroid cancer survivors in china: a qualitative study
    Zhu, Pingting
    Zhang, Hui
    Wang, Wen
    Gu, Xinyue
    Ding, Yinwen
    Qian, Meiyan
    Shi, Guanghui
    SUPPORTIVE CARE IN CANCER, 2023, 31 (10)
  • [8] Association Between Serum Thyrotropin and Cancer Recurrence in Differentiated Thyroid Cancer: A Population-Based Retrospective Cohort Study
    Qiang, Judy K.
    Sutradhar, Rinku
    Everett, Karl
    Eskander, Antoine
    Lega, Iliana C.
    Zahedi, Afshan
    Lipscombe, Lorraine
    THYROID, 2025, 35 (02) : 208 - 215
  • [9] A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study)
    Jie Ming
    Jing-Qiang Zhu
    Hao Zhang
    Hui Sun
    Jun Wang
    Ruo-Chuan Cheng
    Lei Xie
    Xing-Rui Li
    Wen Tian
    Tao Huang
    BMC Endocrine Disorders, 21
  • [10] A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study)
    Ming, Jie
    Zhu, Jing-Qiang
    Zhang, Hao
    Sun, Hui
    Wang, Jun
    Cheng, Ruo-Chuan
    Xie, Lei
    Li, Xing-Rui
    Tian, Wen
    Huang, Tao
    BMC ENDOCRINE DISORDERS, 2021, 21 (01)